ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Adherence, Outcomes and Adverse Effects in Pediatric Renal Transplant Patients After Early Steroid-Withdrawal and Low-Dose Calcineurin Inhibitor Maintenance Immunosuppression

A. Garcia1, R. Plews1, M. Moran1, F. Trujillo1, A. Martinez1, N. Koizumi2, D. Conti1, J. Ortiz1

1Albany Medical College, Albany, NY, 2George Mason University, Arlington, VA

Meeting: 2022 American Transplant Congress

Abstract number: 1699

Keywords: Prognosis, Psychosocial, Quality of life, Renal function

Topic: Clinical Science » Kidney » 38 - Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Information

Session Name: Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Type: Poster Abstract

Date: Tuesday, June 7, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: To explore adherence and long-term impacts of a sirolimus-based, low-dose calcineurin inhibitor regimen with early steroid withdrawal in pediatric renal transplant recipients.

*Methods: A single-center, retrospective case series focusing on patient and graft survival, medication adherence, rejection rates and incidence of adverse events. Thirteen pediatric renal transplant cases from 2004-2020 managed with an early-steroid withdrawal immunosuppressive combination including low-dose tacrolimus, low-dose mycophenolate mofetil and low-dose sirolimus were included as were seven cases on a traditional steroid-maintenance regimen.

*Results: Twenty total patients received renal transplant at ages between 9 and 17. 31% of the novel regimen experienced graft failure (75% non-adherence; 50% chronic rejection) relative to 57% in the steroid group (75% non-adherence; 100% chronic rejection). Overall, 54% of novel arm patients reported non-adherence compared to 71% in the steroid arm. New-onset adverse events including hypertension (57% vs 43%), viral infection (38% vs 14%), and malignancy (15% vs 0%) occurred more frequently on novel immunosuppression rather than steroid maintenance. However, weight gain (46% vs 86%) occurred less commonly whereas hyperlipidemia (31% vs 29%) and diabetes mellitus (15% vs 14%) were relatively consistent between groups.

*Conclusions: Traditional anti-rejection agents (e.g., calcineurin inhibitors, glucocorticoids) present significant risks in pediatric populations (Tonshoff & Hocker, 2006; Tredger, Brown & Dhawan, 2008; Fehrenbach et al., 2019). By contrast, calcineurin inhibitor avoidance with the use of mTOR inhibitors yields similar graft outcomes with more favorable side effect profiles (Roque et al., 2008). Less adverse events may result in more consistent adherence (Dobbels et al., 2010). However, there remains a lack of comprehensive understanding of downstream impacts of these alternatives in children. Despite proven success in adult populations, our findings suggest significant complications and improved but nonetheless continued non-adherence in pediatric transplants despite glucocorticoid and calcineurin inhibitor avoidance (Conti, Petrov, Elbalhoul & Gallichio, 2008; Lopez-Soler et al., 2017). It follows that more concerted efforts to understand and address non-adherence, as well as continued focus on adverse events that remain present regardless of compliance, are necessary to optimize the outlook for pediatric renal transplant patients.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Garcia A, Plews R, Moran M, Trujillo F, Martinez A, Koizumi N, Conti D, Ortiz J. Adherence, Outcomes and Adverse Effects in Pediatric Renal Transplant Patients After Early Steroid-Withdrawal and Low-Dose Calcineurin Inhibitor Maintenance Immunosuppression [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/adherence-outcomes-and-adverse-effects-in-pediatric-renal-transplant-patients-after-early-steroid-withdrawal-and-low-dose-calcineurin-inhibitor-maintenance-immunosuppression/. Accessed May 9, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences